Ticker Details
Immunic, Inc.
IPO Date:	April 14, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$224.59M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 4.54%
Avg Daily Range (30 D):	$0.49 | 3.34%
Avg Daily Range (90 D):	$0.41 | 3.47%

Institutional Daily Volume
Avg Daily Volume:	.78M
Avg Daily Volume (30 D):	.13M
Avg Daily Volume (90 D):	.54M

Trade Size
Avg Trade Size (Sh.):	230
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	183

Institutional Trades
Total Institutional Trades:	101
Avg Institutional Trade:	$1.9M
Avg Institutional Trade (30 D):	$.96M
Avg Institutional Trade (90 D):	$.93M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.51M
Avg Closing Trade (30 D):	$1.45M
Avg Closing Trade (90 D):	$1.36M
Avg Closing Volume:	41.02K

News

Dec 30, 2025 @ 3:51 PM Celiac Disease Market Report 2025-2035: Drivers, C... Source: Researchandmarkets.Com

Feb 29, 2024 @ 3:40 PM Immunic And 2 Other Stocks Under $2 Insiders Are B... Source: Avi Kapoor

Oct 10, 2023 @ 5:08 PM Why Startek Shares Are Trading Higher By 29%? Here... Source: Lisa Levin

Oct 10, 2023 @ 12:19 PM Why Immunic Shares Are Trading Higher By Around 13... Source: Lisa Levin

Apr 6, 2023 @ 6:10 PM Immunic's (IMUX) Ulcerative Colitis Study Shows Po... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.8	$-1.08	$-.07
Diluted EPS	$-.8	$-1.08	$-.07
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-34.1M	$-32.59M	$-19.3M
Operating Income / Loss	$-35.33M	$-33.24M	$-23.33M
Cost of Revenue
Net Cash Flow	$-31.53M	$171.15M	$-19.65M
PE Ratio

Splits
Apr 27, 2026	1:10
Apr 15, 2019	1:40